Becton Dickinson and Company Limited

Advanced Animal Diagnostics, Inc.

Kevin G Dolan

Dwight Livingston

Robert L Campbell

Eric Fallows

J Bruce Pitner

Glenn P Vonk

Ross Jacobson

Rajashaker Kache

Rosemary B Evans-Storms

Thomas D Haubert

Jasper N Pollard

Ammon David Lentz

Randal A Hoke

Upma Gulati

Herman D Himel, Iv

James A Prescott

Michael L Marshall

Gregory S Kramer

Michael Justin Lizzi

Wendy Dale Woodley

Scott Nicholas Danhof

Melody M H Kuroda

M Scott Ulrich

Stefano Bresolin

John Richard Sink

Artis R Lockhart

Tobias M Heineck

Adam C Curry

Kristin Weidemaier

Andrea Liebmann-Vinson

David S Sebba

Randy J Somerville

Ernie Ritchey

Donald E Gorelick

Robert L Cheek

Miroslaw Bartkowiak

Jorge Carlos Correa

W William Stewart

Reha O Azizoglu

Erin Gooch Carruthers

Erik J Jensen

Lauren K Parker

Nathan F Pope

Laura A Black

Melissa E Langer

Herman Himel

Jeffrey S Ojala

Eric A Fallows

Melody MH Kuroda

Scott N Danhof

Mark A Talmer

Spencer Lovette

David S Sebra

Melody Mh Kuroda

Jack Kessler

Some embodiments provided herein relate to combined assays. In some embodiments, an assay for identifying influenza type A or influenza type B is combined with an assay for determining the sensitivity of an influenza neuraminidase to an antiviral drug.

Methods and kits for the diagnosis of influenza

A computer input device is shown and described. The computer input device includes a housing comprised of a first section and a second section. The first section is configured to house electrical components. The second section is configured to receive an input object. An input reader is operably placed within the second section such that the input reader is configured to receive information from the input object. The computer input device is configured to send the information from the input object to a computer as a computer input.

Computer input device and method of use

Method and kits for the diagnosis of influenza

The present invention provides methods and compositions for detectingexposure in a subject.

Methods and compositions for detecting mycoplasma exposure

Provided herein are methods, systems, and devices for detecting and/or identifying one or more specific microorganisms in a culture sample. Indicator particles, such as surface enhanced Raman spectroscopy (SERS)-active nanoparticles, each having associated therewith one or more specific binding members having an affinity for the one or more microorganisms of interest, can form a complex with specific microorganisms in the culture sample. Further, agitating magnetic capture particles also having associated therewith one or more specific binding members having an affinity for the one or more microorganisms of interest can be used to capture the microorganism-indicator particle complex and concentrate the complex in a localized area of an assay vessel for subsequent detection and identification. The complex can be dispersed, pelleted, and redispersed so that the culture sample can be retested a number of times during incubation so as to allow for real-time monitoring of the culture sample.

Methods, systems, and devices for detecting and identifying microorganisms in microbiological culture samples

The present invention relates to dermal vaccine formulations, designed for targeted delivery of an immunogenic composition to a dermal compartment of skin including the intradermal and epidermal compartments. The dermal vaccine formulations of the invention comprise an antigenic or immunogenic agent, and at least one molecule, e.g., a chemical agent, which enhances the presentation and/or availability of the antigenic or immunogenic agent to the immune cells of the intradermal compartment or epidermal compartment resulting in an enhanced immune response. The dermal vaccine formulations of the invention have enhanced efficacy as the antigenic or immunogenic agent is delivered to the intradermal compartment or epidermal compartment with enhanced presentation and/or availability to the immune cells that reside therein. The enhanced efficacy of the dermal vaccine formulations results in a therapeutically effective immune response after a single intradermal or epidermal dose, with lower doses of antigenic or immunogenic agent than conventionally used, and without the need for booster immunizations.

Molecules enhancing dermal delivery of influenza vaccines

Growing community of inventors

Holly Springs, NC, United States of America

Kevin G Dolan